Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ApopLogic Pharmaceuticals LLC
DescriptionTherapy based on Fas ligand, an apoptotic cell death-inducing molecule with unique proinflammatory properties for the treatment of cancer
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today